WA Anticoagulation Medication Chart

For facilities that treat adult patients

Please note:
Each hospital is required to check with their Pathology laboratory to determine the hospital specific therapeutic target range for unfractionated heparin against a gold standard test (e.g. residual anti-Xa activity).
Because of this hospitals should not use a WA Anticoagulation Chart from another hospital as aPTT target ranges will change from hospital to hospital.

Guidelines and Resources

Supportive clinical guidance documents

  • WATAG NOAC Guidelines (PDF 340KB)
    This resource provides further clinical information to assist clinicians in the prescribing and monitoring of DOACs (Direct-Acting Oral Anticoagulants)

Registry for change

All change requests to the WA Anticoagulation Chart should be lodged to QICM.

Recommendations for change must be evidence based, with the primary objective of improving patient safety.

Produced by

Quality Improvement and Change Management Unit